Primary Peptides Inc.
$218,981.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2023-2024
Canada
The Project will support, in part, development of long-acting candidate peptide therapeutics targeting aberrant TDP-43.